Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT01010373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in I
ClinicalTrials.gov study NCT05891249. IPD Sharing: YES. Countries: 1. Publications: 0.
BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00006213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03303066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q
ClinicalTrials.gov study NCT02928419. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia
ClinicalTrials.gov study NCT01362036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00030550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
ClinicalTrials.gov study NCT01152346. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for
ClinicalTrials.gov study NCT00695396. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients
ClinicalTrials.gov study NCT02323139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00454480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00217386. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
ClinicalTrials.gov study NCT02689622. IPD Sharing: NO. Countries: 2. Publications: 0.
Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05263271. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00923234. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00242515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)
ClinicalTrials.gov study NCT00486720. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00027924. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02676323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.